SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH BY NAME

BROWSE

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

CLINUVEL PHARMACEUTICALS LIMITED (CUV)

Listed on ASX

SHARE PRICES

(updated at weekends)

Former (or subsequent) names

Shareholder links

Our website ranking of CUV: rating 5
(5 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Computershare, Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000CUV3
Address: Level 6 15 Queen Street Melbourne Victoria, Australia, 3000
Tel:  61 3 9660 4900 Fax: 61 3 9660 4999

Date first listed: 13/02/2001
Company Secretary: Mr Darren Keamy
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Pharmaceutical company focused on dermatology

The suspension of trading in the securities of Clinuvel Pharmaceuticals Limited (the " Company") will be lifted immediately, following the release of an announcement regarding a capital raising. Security Code: CUV

06/05/2013

Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY) has successfully raised A$6.3 million via a private placement to international institutional and professional investors ("Placement"). The Placement was conducted at price of A$2.136 per share, representing a 4.3% premium to the 20 day volume weighted average price on April 29 and 15.1% to the closing Price on April 30. There was strong participation in the Placement from institutional investors.

06/05/2013

The securities of Clinuvel Pharmaceuticals Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding a capital raising. Security Code: CUV

03/05/2013

we understand that on or about this date the company consolidated its shares 1 for 10

12/11/2010

name changed from Epitan Limited

01/03/2006

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...


    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    10/09/2020Susan Smith420$21.400$8,988
    03/12/2019Jeffrey Rosenfeld1,093$27.437$29,988
    30/08/2019Karen Agersborg1,400$17.950
    USD
    $25,130
    07/05/2019Karen Agersborg1,200$16.780
    USD
    $20,136
    19/12/2016Stanley McLiesh-898$7.800$7,004

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Willem BlijdorpChairman21/01/2015
    Philippe WolgenCEO01/10/2005
    Darren KeamyCFO07/12/2005
    Karen AgersborgNon Exec Director29/01/2018
    Brenda ShanahanNon Exec Director06/02/2007
    Susan SmithNon Exec Director23/09/2019
    Jeffrey RosenfeldNon Exec Director26/11/2019

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Stanley McLieshNon Exec Chairman12/09/200230/11/2019
    Elia IshagNon Exec Director01/02/201128/11/2017
    Jack WoodNon Exec Director08/07/200828/07/2014
    Helmer AgersborgExecutive Director22/08/200028/09/2012

    Date of first appointment, title may have changed.